We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Eel Fluorescent Protein Revolutionizes Bilirubin Assay

By LabMedica International staff writers
Posted on 01 Jul 2013
A fluorescent protein from freshwater eels could serve as the basis for a revolutionary new clinical test for bilirubin, a critical indicator of human liver function, hemolysis, and jaundice.

Bilirubin is a common marker in blood tests where bilirubin is used by doctors to assess liver function and for the assessment of health, including hemolysis, the loss of red blood cells in anemia. More...


Scientists at the RIKEN Brain Science Institute (Wako, Japan) investigated a fluorescent protein harbored by Unagi (Anguilla japonica) the sea-going Japanese freshwater eel. The team cloned a gene from Unagi for an unusual fluorescent protein they named UnaG, for Unagi Green protein, which allows eels to glow in the dark. UnaG is the first fluorescent protein found in vertebrates; previously they were thought to exist only in simple animals like jellyfish.

The unique nature of UnaG is that it needs a natural chemical to activate its powerful green light emission. The compound was identified by the investigators to be bilirubin, a molecule universally used in clinical laboratories around the world as a human blood marker for liver function. By analyzing the structure of UnaG, the team discovered a novel mechanism of fluorescence enabling bilirubin to bind to UnaG and activate its light emission. With this property, they developed a superior new assay for bilirubin with high sensitivity, accuracy, and speed that may become the global clinical standard, and can be used in developing countries where child liver health is a major issue.

The scientists performed large-scale measurements comparing human serum samples spiked with bilirubin (UC-BR) and volunteer blood samples and were able to demonstrate the applicability of the fluorescent method while emphasizing the limitations of conventional methodology. Due to the simplicity, they propose that the method will be helpful to clinical laboratories worldwide who run blood panels including bilirubin, and, in particular, pediatricians and pediatric caregivers who treat low birth weight infants in whom high levels of UC-BR may cause jaundice and kernicterus.

Atsushi Miyawaki, MD, PhD, the senior author concluded, “We believe that UnaG provides an unexpected foothold into several important but currently obscure areas of human health including bilirubin metabolism and muscle physiology during endurance exercise. Before the discovery of UnaG, I couldn't imagine that basic science could have such a direct impact on human health. From a simple eel, we found a new path to the clinic." The study was published on June 20, 2013, in the journal Cell.

Related Links:
RIKEN Brain Science Institute



Gold Member
Aspiration System
VACUSAFE
Online QC Software
Acusera 24•7
POC Immunoassay Analyzer
Procise DX
Repetitive Pipette
VWR® Stepper Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Using deep sequencing of cell-free fetal DNA from maternal blood and advanced computational analysis, the method reconstructs fetal variants across the exome (Image credit: Adobe Stock)

Noninvasive Sequencing Test Approaches Invasive Genome Sequencing for Prenatal Screening

Prenatal genetic evaluation guides obstetric care, but standard diagnostics often require invasive procedures that carry risks, stress, and access barriers. Noninvasive prenatal testing (NIPT) has expanded... Read more

Microbiology

view channel
Image: The study compares rapid molecular CPE diagnostics, which can return results in about one hour, with culture-based screening, which typically takes about 48 hours (Image credit: Adobe Stock)

Rapid Molecular Screening Aims to Accelerate Hospital Infection Control for CPE

Drug-resistant infections remain a critical patient-safety threat in hospitals, with carbapenemase-producing Enterobacterales (CPE) among the most urgent concerns. In England, reports of acquired carbapenemase... Read more

Pathology

view channel
Image: Overview of the uncertainty-aware lensfree computational pathology platform for automated HER2 assessment. A compact lensfree holographic imaging system captures diffraction patterns from immunohistochemically stained breast tissue samples, which are computationally reconstructed and analyzed using deep neural networks with Bayesian uncertainty quantification. (Photo courtesy of Ozcan Lab, UCLA)

Uncertainty-Aware AI Platform Supports Automated HER2 Assessment in Breast Cancer

Accurate assessment of human epidermal growth factor receptor 2 (HER2) is critical for breast cancer diagnosis and treatment selection, yet scoring variability and infrastructure requirements can complicate... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.